Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $815.6000 (0.94%) ($815.6000 - $815.8300) on Wed. Oct. 4, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.22% (three month average) | RSI | 41 | Latest Price | $815.6000(0.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.4% a day on average for past five trading days. | Weekly Trend | REGN declines -0.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(67%) IBB(60%) DIA(55%) XLF(55%) SPY(51%) | Factors Impacting REGN price | REGN will decline at least -0.61% in a week (0% probabilities). VXX(-44%) VIXM(-40%) TBT(-21%) USO(-20%) GLD(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.61% (StdDev 1.22%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $826.98 | 5 Day Moving Average | $820.15(-0.55%) | 10 Day Moving Average | $824.66(-1.1%) | 20 Day Moving Average | $826.98(-1.38%) | To recent high | -3.5% | To recent low | 17.8% | Market Cap | $86.477b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |